SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001741830-22-000004
Filing Date
2022-02-24
Accepted
2022-02-24 16:02:08
Documents
14
Period of Report
2022-02-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kron-20220224.htm   iXBRL 8-K 37794
2 EX-99.1 kronosq42021ex-991.htm EX-99.1 65296
6 GRAPHIC kronosbio1a.jpg GRAPHIC 30771
  Complete submission text file 0001741830-22-000004.txt   295503

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kron-20220224.xsd EX-101.SCH 1924
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kron-20220224_lab.xml EX-101.LAB 24945
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kron-20220224_pre.xml EX-101.PRE 13156
8 EXTRACTED XBRL INSTANCE DOCUMENT kron-20220224_htm.xml XML 12045
Mailing Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402
Business Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402 212-871-7920
Kronos Bio, Inc. (Filer) CIK: 0001741830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39592 | Film No.: 22670810
SIC: 2834 Pharmaceutical Preparations